Mutations in the epidermal growth factor receptor (EGFR): Retro-and prospective observations in non-small cell lung cancer (NSCLC) patients (pts) treated with gefitinib

被引：0
|
作者：
Nederlof, R
Boerrigter, L
Van 't Veer, L
Baas, P
van Zandwijk, N
机构：
[1] Netherlands Canc Inst, Dept Mol Pathol, Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 50 条
  • [31] Mutation in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer (NSCLC)
    Tsai, C
    Chiu, C
    Chou, T
    Li, L
    Chang, K
    Chen, Y
    Tsai, S
    Perng, R
    [J]. LUNG CANCER, 2005, 49 : S113 - S113
  • [32] Multicenter prospective study of erlotinib in advanced non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations
    Cardenal, Felipe
    Moran, Teresa
    Queralt, Cristina
    Porta, Ruth
    Camps, Carlos
    Majem, Margarita
    Lopez-Vivanco, Guillermo
    Isla, Dolores
    Provencio, Mariano
    Sanchez, Jose Javier
    Taron, Miquel
    Rosell, Rafael
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S324 - S325
  • [33] The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor
    Ryo Ko
    Hirotsugu Kenmotsu
    Yasushi Hisamatsu
    Hiroaki Akamatsu
    Shota Omori
    Kazuhisa Nakashima
    Takuya Oyakawa
    Kazushige Wakuda
    Takehito Shukuya
    Akira Ono
    Hisao Imai
    Tetsuhiko Taira
    Tateaki Naito
    Haruyasu Murakami
    Keita Mori
    Masahiro Endo
    Yasuhisa Ohde
    Kazuhisa Takahashi
    Toshiaki Takahashi
    [J]. International Journal of Clinical Oncology, 2015, 20 : 668 - 673
  • [34] The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor
    Ko, Ryo
    Kenmotsu, Hirotsugu
    Hisamatsu, Yasushi
    Akamatsu, Hiroaki
    Omori, Shota
    Nakashima, Kazuhisa
    Oyakawa, Takuya
    Wakuda, Kazushige
    Shukuya, Takehito
    Ono, Akira
    Imai, Hisao
    Taira, Tetsuhiko
    Naito, Tateaki
    Murakami, Haruyasu
    Mori, Keita
    Endo, Masahiro
    Ohde, Yasuhisa
    Takahashi, Kazuhisa
    Takahashi, Toshiaki
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (04) : 668 - 673
  • [35] Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutations in Non-small Cell Lung Cancer (NSCLC): A Global Meta-analysis
    Melosky, B.
    Laack, E.
    Kambartel, K.
    Haentschel, M.
    Bennetts, M.
    Nickens, D.
    Brinkmann, J.
    Kayser, A.
    Moran, M.
    Cappuzzo, F.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S449 - S449
  • [36] UTILITY OF TESTING FOR NON-SMALL CELL LUNG CANCER (NSCLC) EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS IN AN AUSTRALIAN TESTING PROGRAM
    Peters, M.
    Solomon, B.
    Bowden, J.
    Lewis, J.
    Carpenter, P.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S180 - S180
  • [37] 'Targeting' the epidermal growth factor receptor tyrosine kinase with gefitinib (Iressa®) in non-small cell lung cancer (NSCLC)
    Pao, W
    Miller, VA
    Kris, MG
    [J]. SEMINARS IN CANCER BIOLOGY, 2004, 14 (01) : 33 - 40
  • [38] The quantification of epidermal growth factor receptor (EGFR) in plasma is a prognostic factor in advanced non-small cell lung cancer (NSCLC) patients
    Camps, C.
    Sirera, R.
    Munoz-Navarro, M.
    Lopez-Vivanco, G.
    Alonso, G.
    Provencio, M.
    Gonzalez-Larriba, J.
    de las Penas, R.
    Taron, M.
    Rosell, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [39] Changes in Circulating Epidermal Growth Factor Receptor (EGFR) during Radiotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients
    Ye, Ping
    Zhao, Jing
    Maihle, Nita
    Wang, Shulian
    Jin, Jianyue
    Kong, Feng-Ming
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S605 - S605
  • [40] Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations
    Frega, Stefano
    Lorenzi, Martina
    Fassan, Matteo
    Indraccolo, Stefano
    Calabrese, Fiorella
    Favaretto, Adolfo
    Bonanno, Laura
    Polo, Valentina
    Zago, Giulia
    Lunardi, Francesca
    Attili, Ilaria
    Pavan, Alberto
    Rugge, Massimo
    Guarneri, Valentina
    Conte, PierFranco
    Pasello, Giulia
    [J]. ONCOTARGET, 2017, 8 (20) : 32626 - 32638
12345